GEOVAX LABS, INC. Basic Shares Outstanding (Weighted Average)
GEOVAX LABS, INC. (GOVX) reported Basic Shares Outstanding (Weighted Average) of 4.57 million shares for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-09-17
- GEOVAX LABS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 4.57M shares, a 643.07% increase year-over-year.
- GEOVAX LABS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 2.01M shares, a 319.94% increase year-over-year.
- GEOVAX LABS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was -48.65M shares.
- GEOVAX LABS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 20.29M shares, a 216.75% increase year-over-year.
- GEOVAX LABS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 1.82M shares, a 60.60% increase from fiscal 2022.
- GEOVAX LABS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 1.13M shares, a 81.45% decline from fiscal 2021.
- GEOVAX LABS, INC. weighted average number of shares outstanding, basic for fiscal 2021 was 6.10M shares.
- GEOVAX LABS, INC. weighted average number of shares outstanding, basic for fiscal 2011 was 15.74M shares, a 0.54% increase from fiscal 2010.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed | Weighted Average Number of Shares Outstanding, Basic 126 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.57M shares S-1 · filed 2026-09-17 | 3.29M shares S-1 · filed 2026-09-17 | -14.03M shares derived: average of 3 quarters · filed 2026-09-17 | -5.45M shares derived: average of 4 quarters · filed 2026-09-17 | |||||
| 2026-03-31 | 2.01M shares 10-Q · filed 2026-05-14 | -23.32M shares derived: average of 2 quarters · filed 2026-09-17 | -8.78M shares derived: average of 3 quarters · filed 2026-09-17 | -6.43M shares derived: average of 4 quarters · filed 2026-09-17 | |||||
| 2025-12-31 | -48.65M shares derived: S-1 12 month − 10-Q 9 month · filed 2026-09-17 | -14.18M shares derived: average of 2 quarters · filed 2026-09-17 | -9.25M shares derived: average of 3 quarters · filed 2026-09-17 | 958.44K shares S-1 · filed 2026-09-17 | |||||
| 2025-09-30 | 20.29M shares 10-Q · filed 2025-11-13 | 10.45M shares derived: average of 2 quarters · filed 2026-09-17 | 17.49M shares 10-Q · filed 2025-11-13 | 2.78M shares derived: average of 4 quarters · filed 2026-09-17 | |||||
| 2025-06-30 | 614.37K shares S-1 · filed 2026-09-17 | 15.36M shares 10-Q · filed 2025-07-28 | 543.89K shares S-1 · filed 2026-09-17 | 13.60M shares 10-Q · filed 2025-07-28 | -3.06M shares derived: average of 3 quarters · filed 2026-09-17 | -694.04K shares derived: average of 4 quarters · filed 2026-09-17 | |||
| 2025-03-31 | 478.19K shares 10-Q · filed 2026-05-14 | 11.95M shares 10-Q · filed 2025-05-01 | -4.90M shares derived: average of 2 quarters · filed 2026-09-17 | -1.13M shares derived: average of 3 quarters · filed 2026-09-17 | -212.66K shares derived: average of 4 quarters · filed 2026-09-17 | ||||
| 2024-12-31 | -10.27M shares derived: S-1 12 month − 10-Q 9 month · filed 2026-09-17 | -1.93M shares derived: average of 2 quarters · filed 2026-09-17 | -442.94K shares derived: average of 3 quarters · filed 2026-09-17 | 207.48K shares S-1 · filed 2026-09-17 | 5.19M shares 10-K · filed 2025-03-27 | ||||
| 2024-09-30 | 6.40M shares 10-Q · filed 2025-11-13 | 4.47M shares derived: average of 2 quarters · filed 2025-11-13 | 3.70M shares 10-Q · filed 2025-11-13 | 3.32M shares derived: average of 4 quarters · filed 2025-11-13 | |||||
| 2024-06-30 | 2.54M shares 10-Q · filed 2025-07-28 | 2.33M shares 10-Q · filed 2025-07-28 | 2.30M shares derived: average of 3 quarters · filed 2025-07-28 | 2.16M shares derived: average of 4 quarters · filed 2025-07-28 | |||||
| 2024-03-31 | 2.37M shares 10-Q · filed 2025-05-01 | 2.17M shares derived: average of 2 quarters · filed 2025-05-01 | 2.04M shares derived: average of 3 quarters · filed 2025-05-01 | 1.92M shares derived: average of 4 quarters · filed 2025-05-01 | |||||
| 2023-12-31 | 1.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 1.88M shares derived: average of 2 quarters · filed 2025-03-27 | 1.77M shares derived: average of 3 quarters · filed 2025-03-27 | 1.82M shares 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | 1.77M shares 10-Q · filed 2024-11-12 | 26.54M shares 10-Q · filed 2023-11-08 | 1.67M shares derived: average of 2 quarters · filed 2024-11-12 | 1.76M shares 10-Q · filed 2024-11-12 | 26.44M shares 10-Q · filed 2023-11-08 | -7.96M shares derived: average of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | 1.56M shares 10-Q · filed 2024-08-06 | 26.44M shares 10-Q · filed 2023-08-09 | 1.76M shares 10-Q · filed 2024-08-06 | 26.39M shares 10-Q · filed 2023-08-09 | -11.20M shares derived: average of 3 quarters · filed 2024-08-06 | -2.54M shares derived: average of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | 1.76M shares 10-Q · filed 2024-05-14 | 26.34M shares 10-Q · filed 2023-05-04 | -17.59M shares derived: average of 2 quarters · filed 2024-05-14 | -3.90M shares derived: average of 3 quarters · filed 2024-05-14 | 252.63K shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | -36.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -6.73M shares derived: average of 2 quarters · filed 2024-02-29 | -248.47K shares derived: average of 3 quarters · filed 2024-02-29 | 1.13M shares 10-K · filed 2024-02-29 | 16.97M shares 10-K · filed 2023-03-23 | ||||
| 2022-09-30 | 23.46M shares 10-Q · filed 2023-11-08 | 18.09M shares derived: average of 2 quarters · filed 2023-11-08 | 13.82M shares 10-Q · filed 2023-11-08 | 12.42M shares derived: average of 4 quarters · filed 2023-11-08 | |||||
| 2022-06-30 | 12.72M shares 10-Q · filed 2023-08-09 | 9.93M shares 10-Q · filed 2023-08-09 | 8.74M shares derived: average of 3 quarters · filed 2023-08-09 | 8.14M shares derived: average of 4 quarters · filed 2023-08-09 | |||||
| 2022-03-31 | 7.11M shares 10-Q · filed 2023-05-04 | 6.75M shares derived: average of 2 quarters · filed 2023-05-04 | 6.61M shares derived: average of 3 quarters · filed 2023-05-04 | 6.54M shares derived: average of 4 quarters · filed 2023-05-04 | |||||
| 2021-12-31 | 6.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 6.37M shares derived: average of 2 quarters · filed 2023-03-23 | 6.35M shares derived: average of 3 quarters · filed 2023-03-23 | 6.10M shares 10-K · filed 2023-03-23 | |||||
| 2021-09-30 | 6.35M shares 10-Q · filed 2022-11-09 | 6.34M shares derived: average of 2 quarters · filed 2022-11-09 | 6.01M shares 10-Q · filed 2022-11-09 | ||||||
| 2021-06-30 | 6.32M shares 10-Q · filed 2022-08-03 | 5.83M shares 10-Q · filed 2022-08-03 | |||||||
| 2021-03-31 | 5.33M shares 10-Q · filed 2022-04-27 | ||||||||
| 2011-12-31 | 15.74M shares 10-K · filed 2012-03-30 | 10.70M shares 10-K · filed 2012-03-30 | |||||||
| 2010-12-31 | 15.65M shares 10-K · filed 2012-03-30 | ||||||||
| 2009-12-31 | 15.19M shares 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |